Inventor
GUO AILAN
US32 patents
⚠️ This page may combine multiple inventors who share the name “GUO AILAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELL SIGNALING TECHNOLOGY INC
20 patentsUS7700339B2Apr 20, 2010
Gene defects and mutant ALK kinase in human solid tumors
CELL SIGNALING TECHNOLOGY INC22 citations92
US8383799B2Feb 26, 2013
Translocation and mutant ROS kinase in human non-small cell lung carcinoma
CELL SIGNALING TECHNOLOGY INC5 citations83
US8377642B2Feb 19, 2013
Gene defects and mutant ALK kinase in human solid tumors
CELL SIGNALING TECHNOLOGY INC5 citations83
US11377486B2Jul 5, 2022
Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue
CELL SIGNALING TECHNOLOGY INC2 citations71
US11761005B2Sep 19, 2023
Translocation and mutant ROS kinase in human non-small cell lung carcinoma
CELL SIGNALING TECHNOLOGY INC0 citations62
US11505833B2Nov 22, 2022
Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
CELL SIGNALING TECHNOLOGY INC0 citations62
US10955416B2Mar 23, 2021
Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer
CELL SIGNALING TECHNOLOGY INC0 citations62
US9988688B2Jun 5, 2018
Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
CELL SIGNALING TECHNOLOGY INC1 citations62
US9523130B2Dec 20, 2016
Methods of treating non-small cell lung carcinoma (NSCLC)
CELL SIGNALING TECHNOLOGY INC1 citations62
US9328349B2May 3, 2016
Translocation and mutant ROS kinase in human non-small cell lung carcinoma
CELL SIGNALING TECHNOLOGY INC1 citations62
US9181326B2Nov 10, 2015
Analysis of ubiquitinated polypeptides
CELL SIGNALING TECHNOLOGY INC2 citations62
US12577295B2Mar 17, 2026
Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue
CELL SIGNALING TECHNOLOGY INC0 citations60
US7932044B2Apr 26, 2011
Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-α
CELL SIGNALING TECHNOLOGY INC2 citations59
US11352418B2Jun 7, 2022
Analysis of ubiquitinated polypeptides
CELL SIGNALING TECHNOLOGY INC0 citations51
US10870892B2Dec 22, 2020
Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
CELL SIGNALING TECHNOLOGY INC0 citations51
US10526661B2Jan 7, 2020
Translocation and mutant ROS kinase in human non-small cell lung carcinoma
CELL SIGNALING TECHNOLOGY INC0 citations51
US7977462B2Jul 12, 2011
Tyrosine phosphorylation sites
CELL SIGNALING TECHNOLOGY INC1 citations47
US7807789B2Oct 5, 2010
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
CELL SIGNALING TECHNOLOGY INC1 citations47
US9856315B2Jan 2, 2018
Methylation and acetylation sites
CELL SIGNALING TECHNOLOGY INC0 citations45
US11099188B2Aug 24, 2021
ROS kinase in lung cancer
CELL SIGNALING TECHNOLOGY INC0 citations43
RIKOVA KLARISA
6 patentsUS8481279B2Jul 9, 2013
Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase
RIKOVA KLARISA6 citations83
US8232060B2Jul 31, 2012
Gene defects and mutant ALK kinase in human solid tumors
RIKOVA KLARISA6 citations82
US8288102B2Oct 16, 2012
Gene defects and mutant ALK kinase in human solid tumors
RIKOVA KLARISA5 citations72
US8168383B2May 1, 2012
Gene defects and mutant ALK kinase in human solid tumors
RIKOVA KLARISA5 citations72
US8486645B2Jul 16, 2013
Gene defects and mutant ALK kinase in human solid tumors
RIKOVA KLARISA2 citations61
US8466160B2Jun 18, 2013
Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alpha
RIKOVA KLARISA1 citations45